All News
Voters in These Red States Okay Paid Sick Leave
Voters in Missouri and Nebraska approved ballot measures Tuesday that guarantee paid leave for sick workers. Alaska voters seem poised to pass a similar measure that has a wide lead.
Read MoreSlow Start for AI-Assisted Screening for Diabetic Retinopathy Despite Promise
(MedPage Today) -- While artificial intelligence (AI)-assisted detection of diabetic retinopathy has the potential to expand access to screening, few patients with diabetes have been evaluated with t
Read MoreDiagnostic Delays in Axial Spondyloarthritis
(MedPage Today) -- Expansion of treatment options for axial spondyloarthritis (axSpA) has brought attention to documented delays in diagnosis, which is estimated to be an average of 6.
Read MoreYear in Review: Multiple Sclerosis
(MedPage Today) -- The quest to understand and slow disease progression in multiple sclerosis (MS) continued in 2024, with research revealing possible new treatments and furthering knowledge about th
Read MoreOvercoming the Challenges of Applying CAR T-Cell Therapy to Solid Tumors
(MedPage Today) -- Chimeric antigen receptor (CAR) T-cell therapy has had a transformational impact on the treatment of aggressive hematologic malignancies.
Read MoreSTAT+: Trump’s return raises concerns about funding cuts and politicization at the NIH
Researchers are feeling uneasy about the prospect of NIH budget cuts and politicization of science
Read More'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer
(MedPage Today) -- Actor James Van Der Beek, who starred in the popular 1990s teen drama "Dawson's Creek," revealed he has colorectal cancer. (CNN) And Rep. Gerry Connolly (D-Va.
Read MoreYour Patient Is in Pain. Hear Their Cry.
(MedPage Today) -- The recent heartbreaking story of 18-year-old Nevaeh Crain, a Texas woman who died after she was denied critical care amid complications in her pregnancy, underscores the grave con
Read MoreSTAT+: Pharma giant GSK is quitting industry group BIO
GSK is the fifth biopharma firm to depart BIO in roughly a year.
Read MoreYear in Review: RSV
(MedPage Today) -- This year's headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines -- including a new option, expanded FDA approvals, and updated CDC recom
Read More